Naïve HIV POC Monotherapy Trial

NCT00617526 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: RDEA806 400 mg
DRUG: Placebo
DRUG: RDEA806 1000 mg
DRUG: RDEA806 600 mg
DRUG: RDEA806 800 mg

Sponsor

Ardea Biosciences, Inc.